118 related articles for article (PubMed ID: 37706515)
1. Bruton's Tyrosine Kinase in Ankylosing Spondylitis.
Liao HT; Chen CH
Spine (Phila Pa 1976); 2024 May; 49(10):677-681. PubMed ID: 37706515
[TBL] [Abstract][Full Text] [Related]
2. Janus kinase-1 and 3 in ankylosing spondylitis.
Liao HT; Li TH; Chen CH; Chen HA; Chen WS; Lai CC; Chou CT; Tsai CY
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):134-141. PubMed ID: 29530480
[TBL] [Abstract][Full Text] [Related]
3. Semaphorin 3A in Ankylosing Spondylitis.
Liao HT; Lin YF; Chou CT; Tsai CY
J Microbiol Immunol Infect; 2019 Feb; 52(1):151-157. PubMed ID: 28736223
[TBL] [Abstract][Full Text] [Related]
4. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
Tsang HHL; Chung HY
J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
[TBL] [Abstract][Full Text] [Related]
5. Elevated miR-29a expression is not correlated with disease activity index in PBMCs of patients with ankylosing spondylitis.
Huang J; Song G; Yin Z; Luo X; Ye Z
Mod Rheumatol; 2014 Mar; 24(2):331-4. PubMed ID: 24593209
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of clinical manifestations according to HLA-B(27) genotype in ankylosing spondylitis patients: real-world evidence from smart management system for spondyloarthritis].
Ji XJ; Sun K; Hu ZY; Zhang Y; Ma YP; Sun Z; Li KP; Zhu J; Zhang JL; Huang F
Zhonghua Nei Ke Za Zhi; 2018 Mar; 57(3):179-184. PubMed ID: 29518861
[No Abstract] [Full Text] [Related]
7. Aerobic capacity and its correlates in patients with ankylosing spondylitis.
Hsieh LF; Wei JC; Lee HY; Chuang CC; Jiang JS; Chang KC
Int J Rheum Dis; 2016 May; 19(5):490-9. PubMed ID: 24754841
[TBL] [Abstract][Full Text] [Related]
8. Preliminary study of high mobility group box chromosomal protein 1(HMGB1) in ankylosing spondylitis patients.
Chen Y; Sun W; Li S; Ni J; Su Y; Wang C; Luo X; Tu W; Shen G; Gong F; Zheng F; Dong L
Clin Exp Rheumatol; 2015; 33(2):187-94. PubMed ID: 25602579
[TBL] [Abstract][Full Text] [Related]
9. [The value of erythrocyte sedimentation rate and C-reactive protein in evaluating disease activity in ankylosing spondylitis].
Liu B; Guo CY; Liu WQ; Wu N; Xing Q
Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):566-9. PubMed ID: 16194404
[TBL] [Abstract][Full Text] [Related]
10. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
Kilic E; Kilic G; Akgul O; Ozgocmen S
Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
[TBL] [Abstract][Full Text] [Related]
11. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
J Rheumatol; 1999 Apr; 26(4):980-4. PubMed ID: 10229432
[TBL] [Abstract][Full Text] [Related]
12. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis.
Mermerci Başkan B; Pekin Doğan Y; Sivas F; Bodur H; Ozoran K
Rheumatol Int; 2010 Jan; 30(3):375-81. PubMed ID: 19685057
[TBL] [Abstract][Full Text] [Related]
13. Suppressors of cytokine signalling in ankylosing spondylitis and their associations with disease severity, acute-phase reactants and serum cytokines.
Chen CH; Chen HA; Liao HT; Liu CH; Tsai CY; Chou CT
Clin Exp Rheumatol; 2016; 34(1):100-5. PubMed ID: 26812031
[TBL] [Abstract][Full Text] [Related]
14. Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database.
Arévalo M; Gratacós Masmitjà J; Moreno M; Calvet J; Orellana C; Ruiz D; Castro C; Carreto P; Larrosa M; Collantes E; Font P;
Arthritis Res Ther; 2018 Oct; 20(1):221. PubMed ID: 30285828
[TBL] [Abstract][Full Text] [Related]
15. The clinical usefulness of ESR, CRP, and disease duration in ankylosing spondylitis: the product of these acute-phase reactants and disease duration is associated with patient's poor physical mobility.
Chen CH; Chen HA; Liao HT; Liu CH; Tsai CY; Chou CT
Rheumatol Int; 2015 Jul; 35(7):1263-7. PubMed ID: 25708781
[TBL] [Abstract][Full Text] [Related]
16. Platelet to albumin ratio is an independent indicator for disease activity in ankylosing spondylitis.
Cui R; Wang YL; Tao YL; Tong Q; Chen Z; Dai SM
Clin Rheumatol; 2023 Feb; 42(2):407-413. PubMed ID: 36414863
[TBL] [Abstract][Full Text] [Related]
17. Sleep disturbances are associated with increased pain, disease activity, depression, and anxiety in ankylosing spondylitis: a case-control study.
Li Y; Zhang S; Zhu J; Du X; Huang F
Arthritis Res Ther; 2012 Oct; 14(5):R215. PubMed ID: 23058191
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen-G in ankylosing spondylitis and the response after tumour necrosis factor-alpha blocker therapy.
Chen CH; Liao HT; Chen HA; Liu CH; Liang TH; Wang CT; Tsai CY; Chou CT
Rheumatology (Oxford); 2010 Feb; 49(2):264-70. PubMed ID: 20008091
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between sclerostin level and radiographic changes in patients with ankylosing spondylitis].
Xie J; Yu X
Zhonghua Yi Xue Za Zhi; 2015 May; 95(17):1300-4. PubMed ID: 26081658
[TBL] [Abstract][Full Text] [Related]
20. Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study.
Grazio S; Kusić Z; Cvijetić S; Grubišić F; Balenović A; Nemčić T; Matijević-Mikelić V; Punda M; Sieper J
Rheumatol Int; 2012 Sep; 32(9):2801-8. PubMed ID: 21858541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
